. In contrast to subtyping, the use of psychopathological
dimensions in DSM-5 should substantially improve the ability
to describe the heterogeneity of schizophrenia in a manner that is
more valid and clinically useful (see Barch et al. in this issue for
details) and facilitate measurement-based treatment